Tg Therapeutics (TGTX) EBITDA (2011 - 2026)
Tg Therapeutics' EBITDA was $21.73 million in Q2 2026, down 37.7% from $34.86 million a year earlier and down 37.6% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) EBITDA (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Tg Therapeutics' EBITDA was $136.45 million through Jun 30, 2026, up 58.9% year-over-year; for FY2025, it came in at $123.38 million, up 193.8% from FY2024.
- In earlier years, EBITDA was $42 million in FY2024 (+101.5%), $20.84 million in FY2023, -$217.8 million in FY2022 and -$344.28 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly EBITDA since Q1 2025.
- Compared with a year earlier, EBITDA was higher in four of the last six quarters, with growth averaging 112.7%.
- Per Business Quant data, TGTX's EBITDA in the three quarters before Q2 2026 was $34.83 million (Q1 2026), $50.52 million (Q4 2025) and $29.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Tg Therapeutics | 7.56 Bn | 6.94 Bn | 199.14 Mn | 21.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.96 Mn |
| Mar 31, 2026 | 35.13 Mn |
| Dec 31, 2025 | 50.82 Mn |
| Sep 30, 2025 | 29.69 Mn |
| Jun 30, 2025 | 35.16 Mn |
| Mar 31, 2025 | 8.93 Mn |
| Dec 31, 2024 | 30.27 Mn |
| Sep 30, 2024 | 12.86 Mn |
| Jun 30, 2024 | 9.47 Mn |
| Mar 31, 2024 | -8.60 Mn |
| Dec 31, 2023 | -11.79 Mn |
| Sep 30, 2023 | 115.55 Mn |
| Jun 30, 2023 | -43.95 Mn |
| Mar 31, 2023 | -36.41 Mn |
| Dec 31, 2022 | -76.95 Mn |
| Sep 30, 2022 | -34.37 Mn |
| Jun 30, 2022 | -38.35 Mn |
| Mar 31, 2022 | -66.28 Mn |
| Dec 31, 2021 | -92.43 Mn |
| Sep 30, 2021 | -84.70 Mn |
API Access
Tg Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();